Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04312750Phase 1Completed
Phase 1, open-label, single-arm trial of lidocaine topical system in postherpetic neuralgia (PHN), sponsored by Scilex Holding. Primary endpoint: Mean Cumulative Adhesion Score at 12 hours. Started Dec 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04312750.